Pasithea Therapeutics Corp's total assets for Q were $17.66M, a decrease of -21.17% from the previous quarter. KTTA total liabilities were $1.49M for the fiscal quarter, a -41.06% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.